Curriculum vita

səhifə	3/5
tarix	25.06.2016
ölçüsü	325.5 Kb.

1 2 3 4 5

Is There Difference Between via Pars Plana versus Clear Cornea Cataract Extraction Associated to Vitrectomy? [ARVO Abstract]. Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 5434
M. Ambesi–Impiombato, R. Agurto–Rivera, D. García–Paramo, L. Alvarez–Rivera, N. Ibarra–Ponce, C. Cortés–Luna, A. Suarez–Licona, H. Flores–Huerta, J. Guerrero–Naranjo, and H. Quiróz–Mercado An Improved Method of Internal Limiting Membrane Staining with Trypan Blue and Perfluorocarbon Perfused Vitrectomy (PCPV). [ARVO Abstract]. Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 5427
J.M. Colina–Luquez, A. Pérez–Reguera, A. Meza de Regil, J.L. Guerrero–Naranjo, H. Quiróz–Mercado, and C. Leizaola–Fernández. Treatment of Ischemic Central Retinal Vein Occlusion Macular Edema: Triamcinolone vs. Triamcinolone with Vitrectomy. [ARVO Abstract] Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 5325
R.A. Bueno–Garcia, M. Parrochia, P. Covarrubias, G. Papa Oliva, H. Quiroz–Mercado, R. Naranjo Tackman, L. Estrada, A. Rodríguez– Reyes, and S. Corredor. Corneal Endothelium Perfluocarbon Citotoxicity after Injection of Perfluo–N–Octane in micropigs eyes. [ARVO Abstract] Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 5324
R.A. Garcia Arismendi, L. Wu, F.J. Rodriguez, J. Dalma–Weiszhausz, H. Quiroz–Mercado, V. Morales–Canton, J.L. Rosales–Meneses, J.A. Roca, and J.F. Arévalo. Radial Optic Neurotomy (RON) for Central Retinal Vein Occlusion (CRVO): Results and Complications. [ARVO Abstract]
Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 4796
Solis–Vivanco, J. Fromow–Guerra, A. Meza de Regil, A. Pérez–Reguera, G. Papa–Oliva, H. Quiroz–Mercado, and V. Morales–Cantón. The Effect of Altitude in the Intraocular Pressure after Pars Plana Vitrectomy and Intraocular Sulfur Hexafluoride (SF6) in Rabbits. [ARVO Abstract]
Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 3679
D. Moreno–Paramo, J. Rivera, J. Aranda, M. Jeziorski, F. López–Barrera, G. Alvárez, N. Ibarra, H. Quiroz–Mercado, G. Martínez de la Escalera, and C. Clapp. Endogenous Prolactins Promote Apoptosis in Hyaloid Vessels from Neonatal Rats. [ARVO Abstract] Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 3260
J. Aranda, J. Rivera, H. Quiroz–Mercado, M. Jeziorski, J. Riesgo, G. Nava, G. Martínez de la Escalera, and C. Clapp. Endogenous Prolactins Inhibit Angiogenesis in the Retina. [ARVO Abstract]
Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 452
J.L. Chin, A. Pena–Aceves, D. Aliaga–Tellez, J. Colina–Luque, A. Meza–De Regil, J. Fromow–Guerra, and H. Quiroz–Mercado. Relationship Between Microalbuminuria and Diabetic Macular Edema in Patients with Type 2 Diabetes Mellitus. [ARVO Abstract] Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 390
M. Parrochia, P. Covarrubias, H. Quiroz–Mercado, and J. Jimenez. The Effect of Lisinopril Treatment in ERG Oscillatory Potentials Amplitude in Normotensive Diabetic Type 2 Patients
[ARVO Abstract] Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 349
Amaya–Espinosa, R. Bueno Garcia, A. Perez–Reguera, A. Meza de Regil, and H. Quiroz Mercado. Phacoemulsification with IOL Implantation and Vitrectomy in Severe Proliferative Diabetic Retinopathy. [ARVO Abstract] Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 345
G. Alvarez–Rivera, H. Flores–Orta, R. Flores–Orta, D. Mozas–Dávila, J. Villar–Kuri, M. De Regil, M. Ambesi–Impiombato, N. Ibarra–Ponce, and H. Quiroz–Mercado. Visual Results and Follow Up of Patients with Age Related Macular Degeneration Operated of Phacoemulsification and Intraocular Lens Implantation With and Without Triamcinolone Acetonide. [ARVO Abstract] Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 213
N. Ibarra–Ponce, H. Quiroz–Mercado, J.L. Guerrero–Naranjo, V. Morales–Canton, G. Alvarez–Rivera, C. Cortés–Luna, and D. Moreno–Páramo. Mild Transcleral Cryotherapy for the Treatment of Wet Age Related Macular Degeneration. [ARVO Abstract] Invest. Ophthalmol. Vis. Sci. 2005 46: E-Abstract 212
Hugo Quiroz-Mercado, MD. Minimally invasive 25-G: 2 port, topical anestesia with BIO. American Society of Retina Specialist. 2005 Annual Meeting. Montreal, Canada
Complication after radial optic neurotomy for central vein occlusion. American Academy of Ophthalmology. Chicago, Ill. USA 2005
Is there a difference between via pars plana versus clear cornea cataract extraction in combined surgery with vitrectomy? American Academy of Ophthalmology. Chicago, Ill. USA 2005
D.Yellachich, D.Palanker, D.E. Andersen, M.W. Wiltberger, D.Mordaunt, G.R. Marcellino, V.Morales-Canton, H.Quiroz-Mercado, M.S. Blumenkranz- Semi-Automated Pan-Retinal Photocoagulation in Patients With Diabetic Retinopathy.. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B927
H.Quiroz-Mercado, O.Ustariz-Gonzalez, A.Suarez-Licona, A.Garcia-Carranco, A.Amaya-Espinosa, D.Moreno-Paramo, A.Perez-Reguera, G.Alvarez-Rivera, J.Guerrero-Naranjo, J.Fromow-Guerra Perfluorocarbon Perfused Vitrectomy (pcpv) in Severe Proliferative Diabetic Retinopathy(SPDR) With Traction Retinal Detachment (TRD) - A Comparative Study. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B913
D.Moreno-Paramo, A.Perez - Reguera, A.Meza - de Regil, M.Abraham, M.Parrochia, G.Alvarez-Rivera, O.Ustariz-González, J.Carmona, E.Romo, H.Quiroz – Mercado Safety and Tolerance of Bevacizumab Injection in Rabbit Anterior Chamber. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B706
J.J. Fromow-Guerra, A.Solis-Vivanco, E.Reyna-Castelan, J.Jimenez-Sierra, J.Guerrero-Naranjo, G.Alvarez, M.Martinez, V.Morales-Canton, H.Quiroz-Mercado, The Efficacy of a Single Intravitreal Injection of Bevacizumab in Patients with Diffuse Diabetic Macular Edema. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B892
G.Alvarez-Rivera, J.L. Guerrero-Naranjo, A.Perez-Reguera, D.Moreno-Paramo, E.Reyna, M.Hernandez, A.Solis, M.Abraham, E.Romo, H.Quiroz-Mercado, Is Intravitreous Bevacizumab (Avastin) an Effective Treatment for Venous Occlusions? [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B925

M.A. Martinez-Castellanos, M.Parrochia, H.Quiroz-Mercado, J.L. Guerrero-Naranjo, O.Ustariz, M.Abraham, M.L. Hernandez, M.L. Hernandez, G.Alvarez Safety And Efficacy Of Intravitreal Bevacizumab For Idiopathic Subfoveal Choroidal Neovascularization. Pilot Study. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B953

E.Reyna-Castelan, J.Jimenez-Sierra, A.Solis-Vivanco, J.Fromow-Guerra, G.Alvarez-Rivera, M.Hernandez-Rojas, R.Bueno-Garcia, O.Ustariz-Gonzalez, V.Alfaro, H.Quiroz-Mercado. OCT, Visual Outcome and Angiographic Analysis of Choroidal Neovascularization in Six Eyes with Angiod StreaksTreated with Single Intravitreal Injection of Bevacizumab [RVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B954
M.L. Hernandez, A.Dalma-Weiszhausz, A.Solis-Vivanco, M.Abraham-Marin, G.Alvarez-Rivera, E.Reyna-Castelan, O.Ustariz-Gonzalez, M.Martinez-Castellanos, A.Amaya-Espinosa, H.Quiroz-Mercado. Safety and Efficacy of Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Pathologic Myopia. Pilot Study. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B444
J.Guerrero-Naranjo, R.Bueno-Garcia, H.Quiroz-Mercado, P.Ligguett, V.Alfaro, III, E.Reyna-Castelan, A.Solis-Vivanco^. Security and side Effects of Intravitreal Avastin Using Two Methods of Storage. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B447
A.I. Garcia, E.Reyna-Castelan, G.Alvarez-Rivera, M.Abraham-Marin, D.Moreno-Paramo, O.Ustariz-Gonzalez, J.Guerreo-Naranjo, A.Rodriguez-Reyes, H.Quiroz-Mercado. Biocompatibility of a Lamina Cribrosa Implant in Rabbit and Pig Eyes. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B803
N.H. Timothy, B.Gao, O.Ustariz, D.Moreno, O.Ceron, H.Quiroz-Mercado, E.P. Feener, L.P. Aiello Proteomic Comparison of Standard Undiluted Vitreous Sampling and Large Volume Vitreous Biopsy Obtained by Perfluorocarbon-Perfused Pars Plana Vitrectomy (PCPV). [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B999
O.Ustariz-Gonzalez, A.Suarez-Lincona, H.Quiroz-Mercado, J.Guerrero-Naranjo, A.Perez-Reguera, D.Moreno-Paramo, G.Alvarez-Rivera, A.Amaya-Espinosa, F.Furno-Sola. Bevacizumab Injection in Von Hippel Lindau Disease. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B1048
Wu, H.Quiroz-Mercado, J.Roca, F.Arevalo, M.Farah, J.Fromow, V.Morales-Canton, J.Jimenez, J.Guerrero Safety of an Intravitreal Injection of Bevacizumab (Avastin): Results of a Multicenter Trial. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B641
M.L. Abraham-Marin, M.Hernandez-Rojas, G.Alvarez, C.F. Cortes-Luna, V.Morales-Canton, M.Martinez, O.Ustariz, A.Solis-Vivanco, E.Reyna-Castelan, H.Quiroz-Mercado. Safety and Efficacy of Intravitreal Bevacizumab for Neovascular Age Related Macular Degeneration. Pilot Study. . [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006 B654
E.Romo-Garcia, D.Moreno-Paramo, A.Amaya-Espinosa, A.Suarez-Licona, O.Ustariz-Gonzalez, J.Campuzano, C.Espitia, J.Flores Estrada, H.Quiroz-Mercado, J.Fromow-Guerra Diferential Expression of Vegf And Pedf in Eyes Porcine After Moderate Cryotherapy and Photocoagulation.. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2006; Abstract nr B135
M.Gordon, V.Morales-Canton, A.Solis-Vivanco, M.A. Martinez-Castellanos, E.Reyna-Castelán, M.Hernandez-Rojas, N.Salazar-Teran, J.L. Guerrero-Naranjo, J.Fromow-Guerra, H.Quiroz-Mercado. Complication after Intravitreal Bevacizumab (Avastin): Analysis of 1910 Injections. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B197
E.Romo-Garcia, G.Alvarez-Rivera, M.Gordon, V.Kon-Jara, M.Martinez-Castellanos, D.Moreno-Paramo, J.Guerrero-Naranjo, H.Quiroz-Mercado. Is Intravitreal Bevacizumab an Efective Treatment for Coats Disease?. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B203
J.Guerrero-Naranjo, M.A. Martínez-Castellanos, V.Kon-Jara, M.Gordon, M.Torres-Soriano, A.Solis-Vivanco, N.Salazar-Teran, J.Fromow-Guerra, H.Quiroz-Mercado. Experience of 18 Months in the Use of Intravitreal Bevacizumab in a Single Ophtalmology Center. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B204
M.E. Torres, O.Ustáriz-Gonzáles, V.Kon-Jara, G.García-Aguirre, J.L. Díaz-Rubio, M.Gordon-Angelozz, A.Solis-Vivanco, M.Ober, J.L. Guerrero-Naranjo, H.Quiroz-Mercado. Intravitreal Bevacizumab for the Treatment of Chronic or Recurrent Central Serous Chorioretinopathy. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B343
D.Moreno-Paramo, G.Alvarez-Rivera, M.Abraham- Marín, N.Salazar-Terán, M.A. Martínez-Castellanos, E.Romo-García, M.Hernández-Rojas, J.L. Guerrero-Naranjo, J.Fromow-Guerra, H.Quiroz-Mercado. Intravitreal Bevacizumab (Avastin) as Treatment for Macular Edema in Vein Occlusions. Preliminary Results of a Prospective Study. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B362
O.Alvarez-Verduzco, M.Torres-Soriano, E.Reyna-Castelan, M.Hernandez-Rojas, J.L. Díaz-Rubio, G.García-Aguirre, J.L. Guerrero-Naranjo, J.M. Jiménez-Sierra, H.Quiroz-Mercado. Tractional Retinal Detachment after Intravitreal Injection of Bevacizumab in Proliferative Diabetic Retinopathy. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B468
A.Barrera, V.Cubas-Lorenzo, A.Solis-Vivanco, H.Quiroz-Mercado, J.Fromow-Guerra, J.Guerrero-Naranjo. Contamination of Bevacizumab (Avastin) Glass Vials. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B609
H.Quiroz-Mercado, M.A. Martinez-Castellanos, O.Ustariz-Gonzalez, G.Alvarez- Rivera, I.Yeshurun, J.Fromow-Guerra. The Use of 3D System Maximizes the Advantages of the Perfluorocarbon Perfused Vitrectomy (PCPV). [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B842
A.Perez Montesinos, M.E. Torres-Soriano, V.Kon-Jara, J.Diaz-Rubio, M.Hernandez-Rojas, V.Cubas-Lorenzo, O.Martinez-Guzman, J.Fromow-Guerra, H.Quiroz-Mercado, J.M. Jimenez-Sierra. Electrophysiologic Changes with Intravitreal Bevacizumab in Patients with Proliferative Diabetic Retinopathy. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B45
N.Salazar-Teran, V.Kon-Jara, O.Ustariz-Gonzalez, E.Reyna-Castelan, J.Fromow-Guerra, H.Quiroz-Mercado. Does Avastin Change Evolution in Juxtafoveal Telangiectasias?. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B304
O.Ustariz-Gonzalez, M.Abraham-Marin, M.Gordon-Angelozzi, A.Suarez-Licona, V.Kon-Jara, M.Torres-Soriano, N.Salazar-Terán, J.Dalma-Weiszhausz, H.Quiroz-Mercado. Treatment of Choroidal Neovascularization (CNV) Associated With Age Related Macular Degeneration (AMD) With Photodynamic Therapy and Bevacizumab (Avastin) Injection. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B233
G.Garcia-Aguirre, E.Reyna-Castelan, M.Torres, V.Kon-Jara, H.Quiroz-Mercado. Intravitreal Bevacizumab vs. Panretinal Photocoagulation for the Treatment of Proliferative and Severe Non-proliferative Diabetic Retinopathy: A Contralateral Eye Study. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B189
R.M. Romero, G.Monares, J.C. De la Luz, A.Morales, G.Padilla, A.Niño-Pecina, H.Quiroz-Mercado. Randomized, Double Blind, Controlled Study with Verteporfin Photodynamic Therapy and Intravitreal Triamcinolone(IVTA) vs Triple Theraphy with Verteporfin Photodynamic Therapy, Intravitreal Triamcinolone and Intravitreal Ranibizumab in Patients with Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration(AMD). [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B181
M.A. Martinez-Castellanos, J.L. Domenzain-Afendulis, M.L. Hernandez-Rojas, A.Solis-Vivanco, N.Salazar-Teran, J.L. Villa-Aja, J.L. Guerrero-Naranjo, R.V. P. Chan, H.Quiroz-Mercado. Safety and Efficacy of Intravitreal Bevacizumab for Retinopathy of Prematurity. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B194

J.Rivera, D.Moreno-Páramo, J.Aranda, E.Arnold, F.López-Barrera, N.Salazar, H.Quiroz-Mercado, G.Martínez de la Escalera, C.Clapp. Prolactin Decreases in the Circulation of Patients with Proliferative Diabetic Retinopathy: Relationship to Intraocular Vasoinhibins. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B464

V.Kon-Jara, M.Torres-Soriano, J.Diaz-Rubio, M.Hernandez-Rojas, J.Guerrero- Naranjo, J.Fromow-Guerra, H.Quiroz-Mercado. Efficacy of Retreatments With Bevacizumab in Choroidal Neovascularization. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B496
H.Sakaguchi, E.Yonezawa, H.Kanda, M.Ozawa, M.Kamei, T.Fujikado, O.Ustariz-Gonzalez, A.Solis-Vivanco, H.Quiroz-Mercado, Y.Tano. Artificial Vision by Direct Optic Nerve Electrode (AV-DONE) for a Patient with Retinitis Pigmentosa. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr 4442
M.H. Berrocal, H.Quiroz-Mercado, L.Wu, J.Roca, M.Maia, M.Farah, V.Morales, F.Graue, J.F. Arevalo, F.J. Rodriguez, Pan-American Collaborative Retina Study Group. Intravitreal Bevacizumab for the Treatment of CNV Not Associated to Age-related Macular Degeneration: Results of the Panamerican Collaborative Retina Study Group (PACORES) [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr 4935
J.Diaz-Rubio, Sr., V.Kon, M.Torres, G.Garcia, M.Gordon, D.Ochoa, V.Morales, J.Guerrero, J.Fromow, H.Quiroz-Mercado. Comparison of Two High-Density Silicone Oils in Complicated Rhegmatogenous Retinal Detachment. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B71
J. Fromow-Guerra, F.J. Arevalo, H.Quiroz-Mercado, J.G. Sanchez, F.E. Michel, M.H. Berrocal, J.A. Roca, M.J. Saravia, L.Wu, Pan-American Collaborative Retina Study Group(PACORES). Primary Intravitreal Bevacizumab (Avastin) for the Treatment of Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD): Results of the Pan-American Collaborative Retina Study Group (PACORES) at 6-Months Follow-Up. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B 250
J.Arevalo¹, J.Fromow-Guerra², H.Quiroz-Mercado², J.G. Sanchez¹, L.Wu³, M.Maia⁴, M.H. Berrocal⁵, A.Solis-Vivanco², M.E. Farah⁴, Pan-American Collaborative Retina Study Group (PACORES). Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema: Results of the Pan-American Collaborative Retina Study Group at 6-Months Follow-Up. [ARVO Abstract] Invest Ophthalmol Vis Sci. 2007; Abstract nr B 175
Raul Velez Montoya, MD, Maximiliano Gordon-Angelozzi MD, Virgilio Morales-Canton MD, Jans Fromow-Guerra MD, Maria Ana Martinez-Castellanos MD, Nelida Salazar-Teran MD, Orlando Ustariz-Gonzalez MD, Mitzy Elena Torres Soriana MD, Gerardo Garcia-Aguirre MD, Jose L Diaz-Rubio MD, Veronica Kon-Jara MD, Jose Luis Guerrero-Naranjo MD, Juan Jimenez-Sierra MD, Hugo Quiroz-Mercado MD. Complications after intravitreal bevacizumab (Avastin) analysis of 2844 injections. American Academy of Ophthalmology. (AAO) New Orleans, LA, USA 2007. Scientific Poster 189
Maria H Berrocal MD, Hugo Quiroz-Mercado MD, Lihteh Wu MD, Jans Fromow-Guerra MD, Mauricio Maia MD, Jose A Roca MD, Michel Eid Farah MD, Federico A Graue-Wiechers MD, Virgilio Morales-Canton MD J Fernando Arevalo MD, Francisco J Rodriguez MD, Fabio B Aggio MD, Carmen Lizanaz MD, Maria A Caastellanos MD. Intravitreal bevacizumab (Avastin) for the treatment of CNV not associated with AMD: Results of the Pan-American Collaborative Retina Study Group (PACORES). American Academy of Ophthalmology. (AAO) New Orleans, LA, USA 2007. Scientific Poster 213
Mitzy Elena Torres Soriano MD, Orlando Ustariz-Gonzalez MD, Veronica Kon-Jara MD, Gerardo Garcia-Aguirre MD, Jose L Diaz-Rubio MD, Maximiliano Gordon-Angelozzi MD, Adriana Solis-Vivanco MD, Michael Ober MD, Jose Luis Guerrero-Naranjo MD, Hugo Quiroz-Mercado MD. Intravitreal bevacizumab for the treatment of chronic or recurrent central serous chorioretinopathy. American Academy of Ophthalmology. (AAO) New Orleans, LA, USA 2007. Scientific Poster 431
J.F. Arevalo, J. Fromow-Guerra, H. Quiroz-Mercado, J.G. Sanchez, L. Wu, M.H. Berrocal, M.E. Farah, M. Maia, J. Cardillo, F.J. Rodrigues, M.J. Saravia. Primary Intravitreal Bevacizumab (Avastin) For Diffuse Diabetic Macular Edema: The Pan-American Collaborative Retina Study Group (Pacores) At 12-Month Follow-Up. XXVIth Meeting of The Club Jules Goninan, St. Moritz-Switzerland, Sept. 2008. Abstract nr 10.
H. Quiroz-Mercado, M.A. Martinez-Castellanos, G. Garcia-Aguirre, O. Honerlage, J.M. Jimenez-Sierra, J.L. Guerrero-Naranjo. Long Term Results (28 Months) On The Use Of Bevacizumab For Retinopathy Of Prematurity. XXVIth Meeting of The Club Jules Gonin, St. Moritz-Switzerland, Sept. 2008. Abstract nr 29.
Veronica A. Kon-Jara, Mitzy Torres-Soriano MD, Gerardo Garcia-Aguirre MD, Jose Luis Diaz-Rubio MD, Jose Luis Guerrero-Naranjo MD, Jans Fromow-Guerra MD, Hugo Quiroz-Mercado MD, Nauman A. Chaudhry MD. The Compass of Wet Age Related Macular Degeneration: Findings after Reinjections with Bevacizumab. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.
Jose Luis Guerrero-Naranjo MD, Adai Perez-Montesinos MD, Raul Velez-Montoya MD, Lourdes Lopez-Ramos MD, Sanra E Vera-Rodriguez MD, Maria A. Martinez-Castellanos MD, Jans Fromow-Guerra MD, Virgilo Morales-Canton MD, Hugo Quiroz-Mercado MD. Pattern Scan Laser System vs. Regular Photocoagulation System: Changes in Contrast Sensitivity Post Treatment in Patients with Diabetic Retinopathy. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.

Hugo Quiroz-Mercado MD, Gerardo Garcia-Aguirre MD, Reyna-Castelan MD, Mitzy Torres-Soriano MD, Veronica Kon-Jara MD, Jans Fromow-Guerra MD, Jose Luis Guerrero-Naranjo MD, Virgilio Morales-Canton MD. Intravitreal Bevacizumab vs. Panretinal Photocoagulation for the Treatment of PDR and SNPDR: A Contralateral Eye Study. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.

Kourous A. Rezaei MD, Kirk H. Packo MD, Stanley Chang MD, Mathew W. MacCumber MD, PhD, Fabio Patelli MD, John S. Pollack MD, Hugo Quiroz-Mercado MD, David F. Williams MD. Retinaws: When the Going Gets tough, the Tough Get Going-Challenging Cases in Vitreoretinal Surgery. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.
Virgilio Morales-Canton MD, Jose Luis Guerrero-Naranjo MD, Maria A. Martinez-Castellanos MD, Hugo Quiroz-Mercado MD, Gerardo Garcia-Aguirre MD, Omar Honerlage-Merino MD, Juan Manuel Jimenez-Sierra MD. Electroretinogram Findings after Intravitreal Bevacizumab for Retinopathy of Prematurity. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.
Pravin U. Dugel MD, Mark S. Blumenkranz MD, Wayne Solley MD, David M Kleinman MD, Joel Naor MD, David A. Weber PhD, George A. Williams MD, Julia A. Haller MD, Hugo Quiroz-Mercado MD. Sirolimus (Rapamycin) Formulated for Local Delivery; Safety and Tolerability in Diabetic Macular Edema and Exudative Age-related Macular Degeneration. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.
Virgilio Morales-Canton MD, Eduardo Torres-Porras MD, Raul Velez-Montoya MD, Jans Fromow-Guerra MD, Octavio Burgos MD, Maurice B. Landers MD, Hugo Quiroz-Mercado MD. The Effect of Unilateral Intravitreal Bevacizumab (Avastin), in the Treatment of Diffuse Bilateral Diabetic Macular Edema: A Pilot Study. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.
Hugo Quiroz-Mercado MD, Raul Velez-Montoya MD, Orlando Ustariz-Gonzalez MD, Gerardo Garcia-Aguirre MD, Maria Ana Martinez-Castellanos MD, Maximiliano Gordon-Angelozzi MD, Mitzy Torres-Soriano MD, Humberto Ruiz-Garcia MD, Jose Luis Guerrero-Naranjo MD, Virgilio Morales-Canton MD, Jans Fromow-Guerra MD. Vascular Endothelial Growth Factor Levels in Aqueous, Vitreous, Blood and Subretinal Fluid in Patients with State V Retinopathy of Prematurity. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.
Jans Fromow-Guerra MD PhD, Maria Lourdes Lopez-Ramos MD, Raul Velez-Montoya MD, Sandra Elizabeth Vera-Rodriguez MD, Adai Perez-Montesinos MD, Maria Ana Martinez-Castellanos MD, Oscar Alvarez-Verduzco MD, Jessica Lopez-Miranda MD, Virgilio Morales-Canton MD, Hugo Quiroz-Mercado MD. Pattern Scan Laser (PaScaL®) System vs. Conventional Photocoagulation: Changes in Macular Thickness after Treatment. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.
Virgilio Morales-Canton MD, Sandra Elizabeth Vera-Rodriguez MD, Raul Velz-Montoya MD, Maria Lourdes Lopez-Ramos MD, Adai Perez-Montesinos MD, Maria Ana Martinez-Castellanos MD, Octavio Burgos-Vejar MD, Jessica Lopez-Miranda MD, Jans Fromow-Guerra MD, Hugo Quiroz-Mercado MD. Pattern Scan Laser System (Pascal) vs. Conventional Photocoagulation System: Electroretinogram Changes after Treatment. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.
Hugo Quiroz-Mercado MD, Raul Velez-Montoya MD, Orlando Ustariz-Gonzalez MD, Gerardo Garcia-Aguirre MD, Maria Ana Martinez-Castellanos MD, Maximiliano Gordon-Angelozzi MD, Mitzy torres-Soriano MD, Humberto Ruiz-Garcia MD, Jose Luis Guerrero-Naranjo MD, Virgilio Morales-Canton MD, Jans Fromow-Guerra MD. Vascular Endothelial Growth Factor Levels in Aqueous, Vitreous, Blood and Subretinal Fluid in Patients with State V Retinopathy of Prematurity. American Society of Retina Specialists 26^th annual Meeting, Maui, Hawaii. Oct. 2008.
Jeffrey L. Olson MD, Naresh Mandava, MD, Scott C. Oliver MD, Hugo Quiroz-Mercado MD, R.J. Courtney. Intravitreal Inhibition of Choroidal Neovascularization in an Animal Model: A Comparison of Infliximab, Anakinra and LD22-4. Retina Congress, New York. Oct. 2009.
Veronica A. Kon-Jara MD, Peter E. Liggett MD, Juner Colina, Gregory M. Haffner MD, Nauman Chaudhry MD, Hugo Quiroz-Mercado MD. Ranibizumab + TTT-ICG Based Photodynamic Therapy in the Treatment of Choroidal Melanoma. Retina Congress, New York. Oct. 2009.
Jose Luis Diaz Rubio MD, Virgilio Morales-Canton MD, Hugo Quiroz-Mercado MD, Maria de Lourde Lopez-Ramos, Juan Manual Jimenez Sierra. Combined Bevacizumab Plus Photodynamic Therapy with Verteporfin in a Circumscribed Choroidal Hemangioma: Case Report. Retina Congress, New York. Oct. 2009.
Peter K. Kaiser MD, Darius M. Moshfeghi MD, Steven R. Sanislo MD, Raul Valez-Montoya , MJ Lopez-Miranda, E. Mark Shusterman, Hugo Quiroz-Mercado MD, Virgilio Morales-Canton, MD, Michael E. Gertner MD. Externally-Applied Sterotactic Orthovoltage Irradiation for Age-Related Macular Degeneration: Case Presentations from a Phase I Clinical Trial. Retina Congress, New York. Oct. 2009.
Virgilio Morales-Canton MD, Raul Velez-Montoya, M. Jessica López-Miranda, Darius Moshfeghi MD, E. Mark Shusterman, Hugo Quiroz-Mercado MD. Oraya’s IRay™: 6 Month Safety and Patient Tolerability. Retina Congress, New York. Oct. 2009.
Darius Moshfeghi MD, Peter K. Kaiser MD, Virgilio Morales-Canton MD, Steven R. Sanislo MD, Raul Velez-Montoya, M. Jessical López-Miranda, E. Mark Shusterman, Hugo Quiroz-Mercado MD, Michael E. Gertner MD. Orthovoltage Irradiation with 24 Gy for Advanced Wet Age-Related Macular Degernation: Case Presentations from Phase I Clinical Trial. Retina Congress, New York. Oct. 2009.

1 2 3 4 5